This approach, often described as surveillance-containment or ring vaccination, helped focus resources where they were most urgently needed.
Instead of depending exclusively on vaccinating every person in every community, health workers could identify cases and protect close contacts and surrounding populations.
The strategy was particularly valuable in areas where healthcare resources were limited and comprehensive vaccination coverage was difficult to achieve.
The last naturally occurring cases
Smallpox eradication was achieved through years of coordinated work involving national governments, international organizations, laboratory specialists, medical personnel, and local communities.
The last known naturally occurring case of smallpox caused by variola major was recorded in Bangladesh in 1975.
In 1977, a case of variola minor was recorded in Somalia. This became the last known naturally occurring case of smallpox.
A separate laboratory-associated smallpox case occurred in the United Kingdom in 1978, highlighting the importance of laboratory safety even as the global eradication campaign approached completion.
On May 8, 1980, the World Health Assembly officially declared that smallpox had been eradicated.
This achievement was historic. Smallpox became the first human disease to be eradicated through a coordinated global public health campaign.
The disappearance of naturally occurring smallpox transformed public health. Routine vaccination was no longer necessary for most of the world's population, and many countries subsequently discontinued their regular smallpox vaccination programs.
The familiar scar on the upper arm became a lasting reminder of the campaign that helped bring this deadly disease to an end.
Why Routine Smallpox Vaccination Eventually Stopped
Once smallpox transmission had been eliminated worldwide, the balance between the benefits and risks of routine vaccination changed.
Smallpox vaccines were highly effective, but they were not entirely risk-free.
Traditional vaccinia-based vaccines could cause serious adverse reactions in a small number of recipients. Certain medical conditions, including some immune deficiencies and particular skin disorders, could increase the risk of complications.
Because smallpox was no longer circulating naturally, routinely vaccinating every child would expose many people to vaccine-related risks without providing the same public health benefit that vaccination had offered when smallpox was widespread.
For this reason, countries gradually discontinued routine smallpox vaccination during the final decades of the twentieth century.
The timing varied by country. Some programs ended earlier than others, and military personnel or certain laboratory workers continued to receive vaccination in specific circumstances.
Today, smallpox vaccination is not part of the routine childhood immunization schedule in most countries.
Specialized vaccination may still be used for particular occupational risks or public health emergencies, depending on national policies and the vaccines available.
It is important to distinguish this change from the abandonment of vaccination as a public health strategy. Smallpox vaccination stopped being routine because the disease had been eradicated, not because vaccines had ceased to be useful.
Smallpox Vaccine Scars Versus BCG Scars: How Are They Different?
One reason the upper-arm scar remains a source of curiosity is that several vaccines can leave visible marks.
In many countries, the BCG vaccine, which helps protect against severe forms of tuberculosis, has also been administered on the upper arm.
As a result, someone who sees a small round scar may wonder whether it came from smallpox vaccination, BCG vaccination, or another skin injury.
Although there are common patterns, appearance alone is not reliable enough to identify the cause with certainty.
Traditional smallpox vaccine scar
Often circular, with a pitted, uneven, or slightly depressed surface. It may be relatively broad or have a distinctive textured appearance.
BCG vaccine scar
Often a small, round mark that may be flat, slightly raised, or mildly indented. Its appearance varies with the person's skin and healing response.
What is the BCG vaccine?
BCG stands for Bacillus Calmette-Guérin. It is a vaccine developed using an attenuated strain of Mycobacterium bovis, a bacterium related to the organism that causes tuberculosis.
Unlike the smallpox vaccine, BCG is not a vaccinia-based vaccine.
BCG is used in many countries, particularly where tuberculosis is more common, to help protect infants and young children against severe forms of the disease, including tuberculous meningitis and disseminated tuberculosis.
Its effectiveness against different forms of tuberculosis varies according to age, disease presentation, population, and other factors.
After BCG vaccination, a small local lesion may develop. It can progress through stages of redness, swelling, a small ulcer, and eventual healing. A scar may remain.
This reaction can take several weeks or months to resolve.
The final scar is usually much smaller than the more conspicuous marks associated with some traditional smallpox vaccinations, although there is considerable variation.
Why appearance alone can be misleading
It is tempting to use the size, shape, or texture of a scar to identify a particular vaccine. However, these characteristics overlap.
A smallpox vaccination scar may be faint. A BCG scar may be more prominent. An ordinary injury can also leave a round or indented mark.
The best clues are a person's vaccination records, childhood medical history, country of birth, and the vaccination practices used during the relevant period.
Even those clues may not provide a definitive answer if records are unavailable.
If identifying the scar is medically important, a healthcare professional can review the history and examine the skin. In most cases, however, an old vaccination scar does not require any treatment.
Why Vaccination Practices Differed Between Countries
The history of vaccination is closely connected to geography, public health policy, and the prevalence of particular infectious diseases.
Different countries introduced vaccines at different times and used different childhood immunization schedules.
For example, BCG vaccination has been widely used in countries with a higher burden of tuberculosis, while other countries have adopted more selective policies based on disease risk.
Smallpox vaccination programs also differed according to the timing of local campaigns, vaccine availability, and the age groups targeted.
These differences help explain why people born during the same decade may have different vaccination histories.
Two individuals of similar age may have received different vaccines depending on where they lived as children.